Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms
- PMID: 35488918
- PMCID: PMC9055007
- DOI: 10.1007/s00415-022-11141-8
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms
Abstract
Fatigue in its many forms of physical, mental, and psychosocial exhaustion is a common symptom of post-COVID-19 condition, also known as "Long COVID." Persistent fatigue in COVID-19 patients is frequently accompanied by cognitive dysfunction and neuropsychiatric symptoms; however, less is known about the relationships between these components of post-COVID-19 condition and fatigue itself. Consequently, the present study sought to (1) distinguish the types of fatigue experienced by participants, and (2) investigate whether cognitive deficits across various domains and neuropsychiatric conditions predicted these different types of fatigue. The study included 136 COVID-19 patients referred for neuropsychological evaluation due to cognitive complaints 8 months on average after SARS-CoV-2 infection. Measures included self-reported fatigue (physical, cognitive, and psychosocial), neuropsychiatric questionnaires (assessing symptoms of depression, anxiety, apathy, and executive functioning), a comprehensive neuropsychological assessment, and self-reported quality of life and everyday functioning. Results showed that reports of clinical significant fatigue were pervasive in our sample (82.3% of participants), with physical fatigue rated highest on average relative to the subscale maximum. Elevated levels of apathy, anxiety, and executive dysfunction in neuropsychiatric measures along with executive and attentional difficulties on cognitive tests were found to be consistently important predictors among different types of fatigue. This implicates both cognitive and neuropsychiatric symptoms as predictors of fatigue in post-COVID-19 condition, and stresses the importance of a holistic approach in assessing and considering potential treatment for COVID-19 patients experiencing fatigue.
Keywords: COVID-19; Cognitive complaints; Fatigue; Neuropsychiatric symptoms; Neuropsychology.
© 2022. The Author(s).
Conflict of interest statement
None of the authors have competing interests in the topics addressed throughout the current study.
Figures
Similar articles
-
Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms.Eur J Neurol. 2025 Jan;32(1):e16084. doi: 10.1111/ene.16084. Epub 2023 Oct 5. Eur J Neurol. 2025. PMID: 37797297 Free PMC article.
-
The association of post-COVID-19 fatigue in the acute phase with neuropsychiatric and neurocognitive symptoms trajectory over time and long-term health-related quality of life among Chinese adults.Health Qual Life Outcomes. 2025 May 31;23(1):54. doi: 10.1186/s12955-025-02384-w. Health Qual Life Outcomes. 2025. PMID: 40450337 Free PMC article.
-
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection.Eur J Neurol. 2023 Dec;30(12):3968-3978. doi: 10.1111/ene.16027. Epub 2023 Aug 26. Eur J Neurol. 2023. PMID: 37540896
-
Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome.Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1945-1957. doi: 10.1007/s00406-024-01863-3. Epub 2024 Jul 24. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39048833 Free PMC article.
-
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.J Neurol Sci. 2022 Mar 15;434:120162. doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29. J Neurol Sci. 2022. PMID: 35121209 Free PMC article. Review.
Cited by
-
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.J Neural Transm (Vienna). 2024 Mar;131(3):203-212. doi: 10.1007/s00702-024-02749-3. Epub 2024 Feb 12. J Neural Transm (Vienna). 2024. PMID: 38347175 Free PMC article. Review.
-
Cognitive and emotional predictors of quality of life and functioning after COVID-19.Ann Clin Transl Neurol. 2024 Feb;11(2):302-320. doi: 10.1002/acn3.51952. Epub 2023 Dec 21. Ann Clin Transl Neurol. 2024. PMID: 38130039 Free PMC article.
-
Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study.J Clin Med. 2023 Sep 13;12(18):5939. doi: 10.3390/jcm12185939. J Clin Med. 2023. PMID: 37762880 Free PMC article.
-
The Impact of COVID-19 Lockdown Measures and COVID-19 Infection on Cognitive Functions: A Review in Healthy and Neurological Populations.Int J Environ Res Public Health. 2023 Mar 10;20(6):4889. doi: 10.3390/ijerph20064889. Int J Environ Res Public Health. 2023. PMID: 36981800 Free PMC article. Review.
-
The Psychiatric Consequences of Long-COVID: A Scoping Review.J Pers Med. 2022 Oct 26;12(11):1767. doi: 10.3390/jpm12111767. J Pers Med. 2022. PMID: 36579511 Free PMC article.
References
-
- Organization WH (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus. 6 Oct 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond...
-
- Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Heal Behav. 2020;8:61–69. doi: 10.1080/21641846.2020.1778227. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous